Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Pfizer

    Tag: Pfizer

    You Searched For "Pfizer"
    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Medical Dialogues Bureau12 April 2020 8:24 AM GMT
    New York: U.S. drugmaker Pfizer Inc said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients...
    Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)

    Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)

    Medical Dialogues Bureau5 April 2020 8:45 AM GMT
    New York: Pfizer Inc. has announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal antibody (mAb) and biosimilar...
    USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema

    USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema

    Medical Dialogues Bureau29 March 2020 5:57 AM GMT
    AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects
    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Medical Dialogues Bureau28 March 2020 8:00 AM GMT
    Hertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
    Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine

    Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine

    Medical Dialogues Bureau22 March 2020 3:30 AM GMT
    New York: Pfizer Inc. has announced top-line results from one of its Phase 3 studies, which evaluated the safety and immunogenicity of its 20-valent...
    Pfizer, Biontech join hands to co-develop mRNA-based coronavirus vaccine

    Pfizer, Biontech join hands to co-develop mRNA-based coronavirus vaccine

    Medical Dialogues Bureau19 March 2020 5:30 AM GMT
    New York & Mainz: Pfizer Inc.and BioNTech SE has announced that the companies have agreed to a letter of intent regarding the co-development and...
    USFDA accepts regulatory submission for tanezumab for management of chronic pain  due to osteoarthritis

    USFDA accepts regulatory submission for tanezumab for management of chronic pain due to osteoarthritis

    Medical Dialogues Bureau7 March 2020 4:30 AM GMT
    Tanezumab is a monoclonal antibody that is part of an investigational class of non-opioid chronic pain medications known as nerve growth factor (NGF)...
    Sanjeev Narula CFO Pfizer Upjohn  appointed as incoming CFO of Viatris

    Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris

    Medical Dialogues Bureau28 Feb 2020 8:15 AM GMT
    Viatris is the new company that will result from the planned combination of Mylan and Upjohn
    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    Medical Dialogues Bureau2 Jan 2020 9:18 AM GMT
    New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    Medical Dialogues Bureau24 Dec 2019 4:15 AM GMT
    Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
    Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production

    Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production

    Medical Dialogues Bureau28 Nov 2019 3:30 AM GMT
    New Delhi: Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018,...
    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Farhat Nasim20 Nov 2019 7:14 AM GMT
    New Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X